Company Filing History:
Years Active: 2020
Title: Niklas Ahlborg: Innovator in Immunology
Introduction
Niklas Ahlborg is a prominent inventor based in Nacka Strand, Sweden. He has made significant contributions to the field of immunology, particularly in the development of therapeutic methods for immune-related conditions. His innovative work has led to the filing of a patent that addresses critical health issues.
Latest Patents
Niklas Ahlborg holds a patent for a composition, kit, and method for the inhibition of IL-21 mediated activation of human cells. This patent, which is crucial for the treatment of various immune-related diseases, includes a synergistic composition that comprises two agents. The first agent is an antibody or antibody fragment directed to a first epitope of IL-21, while the second agent targets a second epitope of IL-21. This invention aims to inhibit and/or neutralize IL-21 mediated activation of human cells, which is essential for the prophylaxis and treatment of inflammatory diseases, autoimmunity, and lymphomas. He has 1 patent to his name.
Career Highlights
Niklas Ahlborg is associated with Mabtech AB, a company known for its advancements in immunological research and diagnostics. His work at Mabtech AB has allowed him to focus on innovative solutions that address pressing health challenges.
Collaborations
Niklas collaborates with Staffan Paulie, who is also involved in the field of immunology. Their partnership enhances the research and development efforts at Mabtech AB.
Conclusion
Niklas Ahlborg's contributions to immunology through his patent and work at Mabtech AB highlight his commitment to advancing medical science. His innovative approaches are paving the way for new treatments for immune-related conditions.